Digital biomarkers are biomarkers based on non-invasive and continuous data collected via devices like wearables and smartphones, analyzed using advanced analytics to extract previously invisible insights. These biomarkers have been shown to be important in developing early diagnostics for mental health conditions, physiological disease, and viral pathogen outbreaks. Digital biomarkers are an increasingly critical underpinning to digital health tools such as digital therapeutics, and the remote monitoring and mHealth components of telehealth, and the broader trend of healthcare transitioning from being provider-centric to patient-centric. In this report, we will explore the readiness of digital biomarkers for entry to market, identifying opportunities in this space.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)